Pharmaron Manufacturing Services (UK) Ltd
Registered name: PHARMARON MANUFACTURING SERVICES (UK) LTD
Pharmaron Manufacturing Services (UK) Ltd made £8.9m revenue and a £13.3m loss in the year to 31 Dec 2025.
Pharmaron Manufacturing Services (UK) Ltd’s revenue grew 1% to £8.9m in the year to 31 Dec 2025, with a loss of £13.3m. The company is classified under “manufacture of other organic basic chemicals” and is based in Cramlington; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Cramlington, North East
- Age
- 22 yrs · since 2004
- Type
- Private Limited Company
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £5.1m | £7.5m | £8.9m | £8.9m |
| Cost of sales | £2.6m | £1.1m | £2m | −£1.3m |
| Gross profit | £2.5m | £6.4m | £6.9m | £7.7m |
| Operating profit | −£24.4m | −£13.7m | −£13.6m | −£12.2m |
| Profit before tax | −£24.4m | −£16.1m | −£16.3m | −£13.3m |
| Profit after tax | — | — | — | −£13.3m |
| Profit (best available) | −£24.4m | −£16.1m | −£16.3m | −£13.3m |
| Staff costs | £7.3m | £8m | £8.3m | — |
| Employees (average) | 148 | 138 | 138 | — |
| Ratios | ||||
| Profit margin | −478.5% | −214.6% | −184.4% | −149.5% |
| Gross margin | 49.8% | 85.5% | 77.4% | 85.7% |
| Revenue per employee | £34.4k | £54.3k | £64.2k | — |
| Profit per employee | −£165k | −£116k | −£118k | — |
| Growth (year on year) | ||||
| Revenue growth | — | ▲47% | ▲18.3% | ▲0.8% |
| Headcount growth | — | ▼6.8% | 0% | — |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £3.5m | £2.8m | £1.8m | — |
| Net assets | £48.2k | −£25.8m | −£21.7m | — |
| Debtors | £346k | £2.4m | £1.7m | — |
| Source | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Jun 2025 | Accounts · bulk data Aug 2026 |
How the business works
- Profit margin
- −149.5%
- Profit ÷ revenue.
- Gross margin
- 85.7%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now —
- Cash at bank
- —
- Now —
- Headcount
- —
- Now —
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Similar profitable businesses
- Ascot Laboratories LimitedBorehamwood · Manufacture of basic pharmaceutical products
- Revenue
- £8.9m
- Profit
- £645k
- Staff
- 66
- New Nordic LimitedLyndhurst · Manufacture of basic pharmaceutical products
- Revenue
- £7.4m
- Profit
- £125k
- Staff
- 5
- Vector Consumer LimitedPrenton · Manufacture of basic pharmaceutical products
- Revenue
- £10.6m
- Profit
- £33.1k
- Staff
- 14
- Pharmapac (U.K.) LimitedBidston, Wirral · Manufacture of basic pharmaceutical products
- Revenue
- £10.8m
- Profit
- £94.7k
- Staff
- 142
- Cosmarida LimitedSheffield · Manufacture of basic pharmaceutical products
- Revenue
- £11.1m
- Profit
- £286k
- Staff
- 90
- Envigo RMS (UK) LimitedLoughborough · Manufacture of basic pharmaceutical products
- Revenue
- £11.4m
- Profit
- £209k
- Staff
- 145
Sources
Latest figures from accounts for the year to 31 Dec 2025 (profit −£13.3m), from the Companies House accounts bulk data published Aug 2026. Spotted an error? Request a correction.
Updated from Companies House on 19 Oct 2026
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.